YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Muscular Dystrophy Drug Repairs Gene, Helps Patients Regain Strength


October 3, 2012 | Sarepta Therapeutics announced ground breaking clinical trial results today, when their drug for Duchenne muscular dystrophy helped patients walk nearly 300 feet farther than patients on placebo, and restored a key protein lacking in some patients. Eteplirsen, the drug, repairs a gene mutation in about 13 percent of Duchenne muscular dystrophy patients, helping them produce a missing protein and regain strength, Sarepta said in its statement. Bloomberg Businessweek
View Next Related Story
Click here to login and leave a comment.  

1 Comments

  • Avatar

    Dear All,
    Great work for Duchenne muscular dystrophy helped patients walk
    I would to like to thanks the teem who did this this research. I would like to ask a question to the expert team- Is this medicine beneficial for Beckar's Muscular dystrophy patient?

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.